Core Viewpoint - The report highlights the growth of industrial enterprises in the Xinjiang Uygur Autonomous Region, indicating a significant increase in the number of large-scale industrial companies and their contribution to the national economy [1]. Group 1: Industrial Growth in Xinjiang - As of January to December 2025, the number of industrial enterprises in Xinjiang is projected to be 5,576, which represents an increase of 438 enterprises compared to the previous year, marking a year-on-year growth of 8.52% [1]. - The industrial enterprises in Xinjiang account for 1.06% of the total number of such enterprises in the country [1]. Group 2: Industry Research and Consulting - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in deep industry research and providing comprehensive consulting services, including industry research reports and feasibility studies [1]. - The firm emphasizes its commitment to delivering high-quality services and market insights to empower investment decisions [1].

证券代码：300106 证券简称：西部牧业 公告编号：临2026-009 新疆西部牧业股份有限公司 2026 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 特别提示： 1.本次股东会无增加、变更、否决提案的情况。 2.本次股东会不涉及变更以往股东会已通过的决议。 3.本次股东会以现场投票和网络投票相结合的表决方式召开。 一、会议召开和出席情况 新疆西部牧业股份有限公司（以下简称"公司"）2026 年第二次临 时股东会于 2026 年 2 月 12 日 14:30 在新疆石河子市开发区北一东路 28 号公司办公楼二楼会议室召开。本次会议采取现场投票与网络投票结合 的表决方式，网络投票由公司委托深圳证券交易所交易系统和互联网投 票系统提供，其中，通过深圳证券交易所交易系统进行网络投票的时间 为 2026 年 2 月 12 日上午 9:15－9:25，9:30－11:30，下午 13:00－15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为 2026年2月 12 日上午 9:15 至下午 15:00。会议由公司董事会召集 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于新疆西部牧业股份有限公司 2026 年第二次临时股东会的 法律意见书 国枫律股字[2026]A0056 号 致：新疆西部牧业股份有限公司（贵公司） 1 定的事实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导 性陈述或者重大遗漏，并承担相应法律责任； 4．本法律意见书仅供贵公司本次会议之目的使用，不得用作任何其他用途。本所 律师同意将本法律意见书随贵公司本次会议决议一起予以公告。 本所律师根据《公司法》《证券法》《股东会规则》《证券法律业务管理办法》《证 券法律业务执业规则》等相关法律、行政法规、规章、规范性文件的要求，按照律师行 业公认的业务标准、道德规范和勤勉尽责精神，对贵公司提供的有关文件和有关事项进 行了核查和验证，现出具法律意见如下： 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司2026年第二次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国 ...

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

智通财经APP讯，西部牧业(300106.SZ)公告，公司2026年1月自产生鲜乳3076.65吨，同比上年减少 2.54%。 ...

智通财经APP讯，西部牧业(300106.SZ)公告，公司2026年1月自产生鲜乳3076.65吨，同比上年减少 2.54%。 ...

关于公司自产生鲜乳销售情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 证券代码：300106 证券简称：西部牧业 公告编号：临 2026-008 新疆西部牧业股份有限公司 2026 年 2 月 5 日 1 新疆西部牧业股份有限公司（以下简称"公司"）主要经营业务 为乳制品加工与销售、饲料生产与销售、自产生鲜乳生产与销售、外 购生鲜乳收购与销售等。根据《深圳证券交易所上市公司自律监管指 引第 3 号——行业信息披露》的相关规定，公司现对养殖业务月度生 产情况进行公告。 | | | 特此公告。 新疆西部牧业股份有限公司董事会 ...

证券日报网讯 2月2日，西部牧业在互动平台回答投资者提问时表示，公司将聚焦乳制品销售核心环 节，优化市场布局、强化品牌影响力，同时以成本精细化管控为重要抓手，持续推进降本提质，努力提 升公司盈利能力及抗风险能力。 （文章来源：证券日报） ...

证券日报网讯2月2日，西部牧业（300106）在互动平台回答投资者提问时表示，截至1月30日公司的股 东总数为2.03万户。 ...

Core Insights - The beverage and dairy sector experienced a rise of 0.51% on January 28, with Liziyuan leading the gains [1] - The Shanghai Composite Index closed at 4151.24, up 0.27%, while the Shenzhen Component Index closed at 14342.9, up 0.09% [1] Sector Performance - Liziyuan (605337) closed at 13.56, up 5.85% with a trading volume of 388,600 shares [1] - Sanyuan (600429) closed at 5.45, up 4.21% with a trading volume of 482,000 shares [1] - Dongpeng Beverage (605499) closed at 254.51, up 3.54% with a trading volume of 47,700 shares [1] - Other notable performers include Weiwe (600300) up 1.65% and Qishi Dairy (920786) up 1.18% [1] Capital Flow - The beverage and dairy sector saw a net inflow of 1.51 million yuan from institutional investors, while retail investors contributed a net inflow of 12.8 million yuan [2] - However, there was a net outflow of 129 million yuan from speculative funds [2] Individual Stock Capital Flow - Liziyuan had a net inflow of 62.55 million yuan from institutional investors, but a net outflow of 17.26 million yuan from speculative funds [3] - Yili (600887) saw a net inflow of 33.78 million yuan from institutional investors, but a significant net outflow of 71.72 million yuan from speculative funds [3] - Sanyuan (600429) had a net inflow of 22.36 million yuan from institutional investors, while retail investors experienced a net outflow of 27.12 million yuan [3]